Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Cancer Research
|
January 12, 2019
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and Are Targetable by BET Bromodomain Inhibition
Matthew L Hemming, Matthew A Lawlor, Jessica L Andersen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 6, 2018
Gastrointestinal stromal tumor enhancers support a transcription factor network predictive of clinical outcome
Matthew L Hemming, Matthew A Lawlor, Rhamy Zeid, et al.
JCO Precision Oncology
|
February 23, 2019
Detection of Circulating Tumor DNA in Patients With Leiomyosarcoma With Progressive Disease
Matthew L Hemming, Kelly S Klega, Justin Rhoades, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 16, 2021
HAND1 and BARX1 Act as Transcriptional and Anatomic Determinants of Malignancy in Gastrointestinal Stromal Tumor
Matthew L Hemming, Shannon Coy, Jia-Ren Lin, et al.
Cancer Discovery
|
May 2, 2022
MOZ and Menin-MLL Complexes Are Complementary Regulators of Chromatin Association and Transcriptional Output in Gastrointestinal Stromal Tumor
Matthew L Hemming, Morgan R Benson, Michael A Loycano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 24, 2022
Preclinical Modeling of Leiomyosarcoma Identifies Susceptibility to Transcriptional CDK Inhibitors through Antagonism of E2F-Driven Oncogenic Gene Expression
Matthew L Hemming, Patrick Bhola, Michael A Loycano, et al.
Nature
|
November 1, 2019
Altered chromosomal topology drives oncogenic programs in SDH-deficient GISTs
William A Flavahan, Yotam Drier, Sarah E Johnstone, et al.
Elife
|
November 16, 2018
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma
Gerard L Brien, David Remillard, Junwei Shi, et al.
Cancers
|
March 6, 2021
Unmet Medical Needs and Future Perspectives for Leiomyosarcoma Patients-A Position Paper from the National LeioMyoSarcoma Foundation (NLMSF) and Sarcoma Patients EuroNet (SPAEN)
Bernd Kasper, Annie Achee, Kathrin Schuster, et al.
Cancer Discovery
|
February 13, 2021
Identification and Therapeutic Targeting of GPR20, Selectively Expressed in Gastrointestinal Stromal Tumors, with DS-6157a, a First-in-Class Antibody-Drug Conjugate
Kenji Iida, Amr H Abdelhamid Ahmed, Akiko Kawano Nagatsuma, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Cancer Research
|
January 12, 2019
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and Are Targetable by BET Bromodomain Inhibition
Matthew L Hemming, Matthew A Lawlor, Jessica L Andersen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 6, 2018
Gastrointestinal stromal tumor enhancers support a transcription factor network predictive of clinical outcome
Matthew L Hemming, Matthew A Lawlor, Rhamy Zeid, et al.
JCO Precision Oncology
|
February 23, 2019
Detection of Circulating Tumor DNA in Patients With Leiomyosarcoma With Progressive Disease
Matthew L Hemming, Kelly S Klega, Justin Rhoades, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 16, 2021
HAND1 and BARX1 Act as Transcriptional and Anatomic Determinants of Malignancy in Gastrointestinal Stromal Tumor
Matthew L Hemming, Shannon Coy, Jia-Ren Lin, et al.
Cancer Discovery
|
May 2, 2022
MOZ and Menin-MLL Complexes Are Complementary Regulators of Chromatin Association and Transcriptional Output in Gastrointestinal Stromal Tumor
Matthew L Hemming, Morgan R Benson, Michael A Loycano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 24, 2022
Preclinical Modeling of Leiomyosarcoma Identifies Susceptibility to Transcriptional CDK Inhibitors through Antagonism of E2F-Driven Oncogenic Gene Expression
Matthew L Hemming, Patrick Bhola, Michael A Loycano, et al.
Nature
|
November 1, 2019
Altered chromosomal topology drives oncogenic programs in SDH-deficient GISTs
William A Flavahan, Yotam Drier, Sarah E Johnstone, et al.
Elife
|
November 16, 2018
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma
Gerard L Brien, David Remillard, Junwei Shi, et al.
Cancers
|
March 6, 2021
Unmet Medical Needs and Future Perspectives for Leiomyosarcoma Patients-A Position Paper from the National LeioMyoSarcoma Foundation (NLMSF) and Sarcoma Patients EuroNet (SPAEN)
Bernd Kasper, Annie Achee, Kathrin Schuster, et al.
Cancer Discovery
|
February 13, 2021
Identification and Therapeutic Targeting of GPR20, Selectively Expressed in Gastrointestinal Stromal Tumors, with DS-6157a, a First-in-Class Antibody-Drug Conjugate
Kenji Iida, Amr H Abdelhamid Ahmed, Akiko Kawano Nagatsuma, et al.
Page
of 3